| Daurkin I, Eruslanov E, Vieweg J, et al.
Generation of antigen-presenting cells from tumor-infiltrated CD11b myeloid cells with DNA demethylating agent 5-aza-2'-deoxycytidine. [JOURNAL ARTICLE]
Cancer Immunol Immunother 2009 Oct 31.
Abstract | Full Citation |
| Matei DE, Nephew KP
Epigenetic therapies for chemoresensitization of epithelial ovarian cancer. [JOURNAL ARTICLE]
Gynecol Oncol 2009 Oct 23.
Abstract | Full Citation |
| Kumar A, List AF, Hozo I, et al.
Decitabine versus 5-azacitidine for the treatment of myelodysplastic syndrome: adjusted indirect meta-analysis. [JOURNAL ARTICLE]
Haematologica 2009 Oct 22.
Full Citation | Find Related Articles |
| Lamba JK
Genetic factors influencing cytarabine therapy. [Journal Article]
Pharmacogenomics 2009 Oct; 10(10):1657-74.
Abstract | Full Citation |
| Paluszczak J, Krajka-Kuźniak V, Baer-Dubowska W
The effect of dietary polyphenols on the epigenetic regulation of gene expression in MCF7 breast cancer cells. [JOURNAL ARTICLE]
Toxicol Lett 2009 Oct 16.
Abstract | Full Citation | Find Related Articles |
| Kastl L, Brown I, Schofield AC
Effects of decitabine on the expression of selected endogenous control genes in human breast cancer cells. [JOURNAL ARTICLE]
Mol Cell Probes 2009 Oct 15.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Gray SG, Al-Sarraf N, Baird AM, et al.
Regulation of EP receptors in non-small cell lung cancer by epigenetic modifications. [JOURNAL ARTICLE]
Eur J Cancer 2009 Oct 7.
Abstract | Full Citation |
| Schaefer M, Hagemann S, Hanna K, et al.
Azacytidine inhibits RNA methylation at DNMT2 target sites in human cancer cell lines. [Journal Article, Research Support, Non-U.S. Gov't]
Cancer Res 2009 Oct 15; 69(20):8127-32.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Son MS, Kang MJ, Park HC, et al.
Expression and mutation analysis of TIG1 (tazarotene-induced gene 1) in human gastric cancer. [Journal Article, Research Support, Non-U.S. Gov't]
Oncol Res 2009; 17(11-12):571-80.
Abstract | Full Citation |
| Ravandi F, Issa JP, Garcia-Manero G, et al.
Superior outcome with hypomethylating therapy in patients with acute myeloid leukemia and high-risk myelodysplastic syndrome and chromosome 5 and 7 abnormalities. [JOURNAL ARTICLE]
Cancer 2009 Sep 30.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
  |
